Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of oral octreotide capsules versus placebo in biochemically controlled acromegaly
MOH_2017-09-04_000785Phase 3Active, not recruiting
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acromegaly comparing Oral octreotide capsules with Matching placebo capsules (2 arms). Primary endpoint: Maintenance of biochemical control. Started Aug 2017; status: active, not recruiting.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on MOH_2017-09-04_000785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-09-04_000785.